Papaioannou et al. [78] reported a correlation between elevated plasma levels of vascular endothelial growth factor (VEGF) in SSc patients and increased sPAP, though another study was not able to corroborate the association between the elevated VEGF levels and CTD-PAH [79]. The gene discussed is VEGFA; the disease is pulmonary arterial hypertension.